Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERGER F. M. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent. J Pharmacol Exp Ther. 1954 Dec;112(4):413–423. [PubMed] [Google Scholar]
- BORRUS J. C. Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states. J Am Med Assoc. 1955 Apr 30;157(18):1596–1598. doi: 10.1001/jama.1955.02950350010005. [DOI] [PubMed] [Google Scholar]
- HARE E. H. Comparative efficacy of hypnotics a self-controlled, self-recorded clinical trial in neurotic patients. Br J Prev Soc Med. 1955 Jul;9(3):140–146. doi: 10.1136/jech.9.3.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- IMBODEN J., LASAGNA L. An evaluation of hypnotic drugs in psychiatric patients. Bull Johns Hopkins Hosp. 1956 Aug;99(2):91–100. [PubMed] [Google Scholar]
- LASAGNA L. A study of hypnotic drugs in patients with chronic diseases; comparative efficacy of placebo; methyprylon (noludar) meprobmate (miltown, equanil) pentobarbial; phenobarbital; secobarbital. J Chronic Dis. 1956 Feb;3(2):122–133. doi: 10.1016/0021-9681(56)90108-4. [DOI] [PubMed] [Google Scholar]
- STRAUS B., EISENBERG J., GENNIS J. Hypnotic effects of an antihistamine; methapyrilene hydrochloride. Ann Intern Med. 1955 Mar;42(3):574–582. doi: 10.7326/0003-4819-42-3-574. [DOI] [PubMed] [Google Scholar]